CHANGZHOU, China, Aug. 2, 2011 /PRNewswire-Asia/ -- China Kanghui Holdings (NYSE: KH) ("Kanghui" or the "Company"), a leading domestic developer, manufacturer and marketer of orthopedic implants in China, today announced that it will hold its 2011 annual general meeting of shareholders at the offices of O'Melveny & Myers LLP, 31/F, AIA Central, 1 Connaught Road Central, Hong Kong, on September 5, 2011 at 2:00 p.m.
The annual general meeting will serve as an open forum for shareholders and beneficial owners of the Company's American Depositary Shares ("ADSs") to discuss Company affairs with management.
The Board of Directors of the Company has fixed the close of business on July 25, 2011 as the record date (the "Record Date") for determining the shareholders entitled to receive notice of the annual general meeting or any adjournment or postponement thereof.
Holders of record of the Company's common shares at the close of business on the Record Date are entitled to attend the annual general meeting and any adjournment or postponement thereof in person. Beneficial owners of the Company's ADSs are welcome to attend the annual general meeting in person.
The Company has filed its annual report on Form 20-F (the "Annual Report"), which includes the Company's audited financial statements for the fiscal year ended December 31, 2010, with the U.S. Securities and Exchange Commission (the "SEC"), which is available at the SEC's website at http://www.sec.gov. The Company's Annual Report can also be accessed from the investor relations section of its website at http://www.kanghui.com.
Holders of the Company's common shares or ADSs may obtain a hard copy of the Annual Report free of charge by emailing Miao Yuenching, Investor Relations Manager, email@example.com by writing to:
China Kanghui Holdings
No. 1-8, Tianshan Road
Xinbei Zone, Changzhou
Jiangsu 213022, China
Attention: Miao Yuenching
About China Kanghui Holdings
Founded in 1997, Kanghui is a leading domestic developer, manufacturer and marketer of orthopedic implants in China. The Company offers a wide array of proprietary orthopedic implant products in trauma and spine. It has an extensive network of distributors for its products in China. In addition, Kanghui's products are distributed in 28 countries. Kanghui has strong research and development capabilities, focused on developing new proprietary products, including new product lines, extensions of existing product lines and enhancements of existing products. For more information, please visit www.kanghui.com.
China Kanghui Holdings Investor Relations Department
Asia Bridge Capital Limited
SOURCE China Kanghui Holdings